The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Levi & Korsinsky, LLP Announces Investigation of Kayak Software Corporation (KYAK) and JDA Software Group Inc. (JDAS) and Class Action Against Questcor Pharmaceuticals, Inc. (QCOR) and Peregrine Pharmaceuticals, Inc. (PPHM)

Tuesday, November 20, 2012

Levi & Korsinsky, LLP Announces Investigation of Kayak Software Corporation (KYAK) and JDA Software Group Inc. (JDAS) and Class Action Against Questcor Pharmaceuticals, Inc. (QCOR) and Peregrine Pharmaceuticals, Inc. (PPHM)13:37 EST Tuesday, November 20, 2012NEW YORK, Nov. 20, 2012 /PRNewswire/ -- (Logo:  http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)Kayak Software CorporationLevi & Korsinsky is investigating the Board of Directors of Kayak Software Corporation (NasdaqGS: KYAK) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to priceline.com Incorporated (NasdaqGS: PCLN) under which shareholders would receive cash and stock valued at approximately $40 per share. Click here to learn more about the investigation: http://zlk.9nl.com/kayak-software-kyak, or call: 877-363-5972. JDA Software Group Inc.Levi & Korsinsky is investigating the Board of Directors of JDA Software Group Inc. (NasdaqGS: JDAS) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to RedPrairie Corp. for $45 per share.Click here to learn more about the investigation http://zlk.9nl.com/jda-software, or call: 877-363-5972.Questcor Pharmaceuticals, Inc.Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who acquired Questcor Pharmaceuticals, Inc. (NasdaqGS: QCOR) securities between April 26, 2011 and September 21, 2012.For more information, click here: http://zlk.9nl.com/questcor-pharmaceuticals-qcor. You have until November 26, 2012 to request that the Court appoint you as lead plaintiff.   Peregrine Pharmaceuticals, Inc.Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who acquired Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities between August 30, 2012 and September 26, 2012.For more information, click here: http://zlk.9nl.com/peregrine-pharmaceuticals-pphm.  You have until November 27, 2012 to request that the Court appoint you as lead plaintiff.Levi & Korsinsky is a national firm with offices in New York and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:     Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky, Esq.30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500Toll Free:  (877) 363-5972Fax: (212) 363-7171www.zlk.com SOURCE Levi & Korsinsky, LLP